Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.
Published February 13, 2019 · Recall initiated: February 1, 2019
Summary
FDA records drug Class II recall D-0424-2019, published February 13, 2019 and initiated February 1, 2019. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 10,390 bottles; Lot: Lot: GA70535, Exp. April 2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: Potential for broken glass in the neck area of the glass bottles.
What to do
Voluntary: Firm initiated · Letter
Get an email if DYMISTA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DYMISTA
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Nationwide in the USA.
- Lot
- Lot: GA70535, Exp. April 2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASoothe & Cool Protect Moisture Guard Skin Protectant (petrolatum 59%),3.5 oz tubes, Manufactured in USA for:February 13, 2019
- FDAMedline Remedy Essential Barrier Skin Protectant Ointment (petrolatum 59%) packaged in a) 2 oz tubes (NDCFebruary 13, 2019
- FDAGE HEALTHCARE LOGIQ P6 Premium TruScan(TM) Imagining Technology: (a) Model BT09 (b) Model BT07 Product Usage:February 6, 2019
- FDASUCTION / ANTICOAGULATION ASSEMBLY (a) BTC93 (b) BTC98 Suction and Anticoagulation assemblies are indicatedFebruary 6, 2019
- FDAAtellica CH 930 Analyzer. In vitro diagnostic testing of clinical specimens Siemens Material Number (SMN): 1February 6, 2019
- FDADymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray,August 15, 2018
Questions about this recall
Was Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23. recalled?
Yes. FDA published recall D-0424-2019 on February 13, 2019. Reported hazard: Defective Container: Potential for broken glass in the neck area of the glass bottles.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DYMISTA.